These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 29306312)
1. [Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80]. Pantín C; Letellez J; Calzas J; Mohedano E Farm Hosp; 2018 Jan; 42(1):27-28. PubMed ID: 29306312 [No Abstract] [Full Text] [Related]
2. [Hypersensitivity reaction to etoposide. A case report]. Mullera Martí M; Riba Solé M; Fernández de Gamarra Martínez E; Mangues Bafalluy MA Farm Hosp; 2014 May; 38(3):255-6. PubMed ID: 24951914 [TBL] [Abstract][Full Text] [Related]
3. Successful rapid desensitization to intravenous etoposide using a 14-step protocol. Garcia Escallon S; Muniyappa PK; Subramanian S J Allergy Clin Immunol Pract; 2015; 3(4):627-8. PubMed ID: 25634221 [No Abstract] [Full Text] [Related]
4. Hypersensitivity reactions to etoposide. Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891 [TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin. Steele RH; Limaye S; Cleland B; Chow J; Suranyi MG Nephrology (Carlton); 2005 Jun; 10(3):317-20. PubMed ID: 15958049 [TBL] [Abstract][Full Text] [Related]
6. Safe administration of oral etoposide after hypersensitivity reaction to intravenous etoposide. Siderov J; Zalcberg J Anticancer Drugs; 1994 Oct; 5(5):602-3. PubMed ID: 7858295 [No Abstract] [Full Text] [Related]
12. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity. Limaye S; Steele RH; Quin J; Cleland B J Allergy Clin Immunol; 2002 Sep; 110(3):530. PubMed ID: 12209107 [No Abstract] [Full Text] [Related]
13. [Reinduction of paclitaxel therapy after a successfully treated hypersensitivity reaction]. Lehoczky O; Bagaméri A; Pulay T Orv Hetil; 2002 Sep; 143(38):2189-91. PubMed ID: 12395475 [TBL] [Abstract][Full Text] [Related]
14. A case of severe immediate type reaction to macrogol and polysorbate 60 after intravaginal drug application. Schwede K; Simon JC; Treudler R Eur J Dermatol; 2019 Jun; 29(3):329-331. PubMed ID: 31389792 [No Abstract] [Full Text] [Related]
15. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants? Singh SK; Mahler HC; Hartman C; Stark CA J Pharm Sci; 2018 Nov; 107(11):2735-2741. PubMed ID: 30055223 [TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide. Webster LK; Linsenmeyer ME; Rischin D; Urch ME; Woodcock DM; Millward MJ Cancer Chemother Pharmacol; 1997; 39(6):557-60. PubMed ID: 9118471 [TBL] [Abstract][Full Text] [Related]
17. Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide. Bernstein BJ; Troner MB Pharmacotherapy; 1999 Aug; 19(8):989-91. PubMed ID: 10453971 [TBL] [Abstract][Full Text] [Related]
18. Delayed Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review. Caballero ML; Quirce S J Investig Allergol Clin Immunol; 2020; 30(6):400-408. PubMed ID: 32376520 [TBL] [Abstract][Full Text] [Related]
19. Vaginal cancer following etoposide-containing chemotherapy for metastatic gestational trophoblastic tumour. Chen RJ; Chen CH; Chou CH; Chang TC; Sheu BC J Obstet Gynaecol; 2012 Feb; 32(2):202-3. PubMed ID: 22296447 [No Abstract] [Full Text] [Related]